Live Breaking News & Updates on Zeneca Alexion Buying
Stay updated with breaking news from Zeneca alexion buying. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZenaca to Buy Rare Disease Specialist Alexion for $39 billion AstraZeneca snaps up Alexion to expand in immunology. PUBLISHED BY AstraZeneca has struck a deal to buy US rare disease specialist Alexion in a $39 billion cash-and-stock agreement. The Anglo-Swedish company has undergone quite a transformation in its fortunes after the successful announcement of its coronavirus vaccine with Oxford University. Just six years ago it was on the brink of being swallowed up by Pfizer. The company’s chief executive officer Pascal Soriot worked hard to revitalize his company’s research and development operation, but it failed to make any big strides in new drugs till its foray into cancer drugs and its recent vaccine success. ....